See all
 |
Articles: Renal/Urologic |
Prior Articles
CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma
Human Pathology, 08/18/09
Pleomorphic giant cell carcinoma of the urinary bladder
Human Pathology, 08/18/09 Renal sclerosing peritubular nodules in a patient with neurofibromatosis type 2: a case report with immunohistochemical and electron microscopic studies
Human Pathology, 08/18/09 Urothelial carcinoma with abundant myxoid stroma
Human Pathology, 08/18/09 Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases
Human Pathology, 08/18/09 Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel
International Journal of Cancer, 08/18/09 Hexyl aminolevulinate fluorescence cystoscopy in bladder cancer
Expert Review of Anticancer Therapy, 08/17/09 HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cells
International Journal of Cancer, 08/17/09 Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy
Journal of Clinical Oncology, 08/14/09 Radiation dose escalation for localized prostate cancer
Cancer, 08/14/09 Sequential adjuvant chemotherapy after surgical resection of high-risk urothelial carcinoma
Cancer, 08/14/09 Small Interfering RNA–Directed Knockdown of Uracil DNA Glycosylase Induces Apoptosis and Sensitizes Human Prostate Cancer Cells to Genotoxic Stress
Molecular Cancer Research, 08/14/09 Differential Influence of Normal and Cancer-Associated Fibroblasts on the Growth of Human Epithelial Cells in an In vitro Cocultivation Model of Prostate Cancer
Molecular Cancer Research, 08/14/09 miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy
Clinical Cancer Research, 08/14/09 Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials
The Lancet Oncology - Online First, 08/13/09 Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer
Cancer Epidemiology, 08/13/09 Age-specific physical activity and prostate cancer risk among white men and black men
Cancer, 08/13/09 Survivin Expression as a Predictive Marker for Local Control in Patients With High-Risk T1 Bladder Cancer Treated With Transurethral Resection and Radiochemotherapy
International Journal of Radiation Oncology*Biology*Physics, 08/13/09 Intermittent hormone therapy and its place in the contemporary endocrine treatment of prostate cancer
Surgical Oncology, 08/13/09 Intrinsic expression of host genes and intronic miRNAs in prostate carcinoma cells
Cancer Cell International, 08/13/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|